Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 November 2024 | Story Leonie Bolleurs | Photo Stephen Collett
SARIMA - 2024
The Directorate Research Development at the university proudly participates in the SARIMA Visibility Project, aimed at enhancing its global visibility and research excellence.

The University of the Free State (UFS) has been selected to participate in a high-impact initiative managed and coordinated by the Southern African Research and Innovation Management Association (SARIMA). The SARIMA Visibility Project, which focuses on elevating institutional prominence, aims to enhance the university’s global visibility and strengthen its capacity to secure international grants. By participating in this initiative, the UFS is positioning the Directorate for Research and Development (DRD) to benchmark against other leading Tier 1 institutions, adopting best practices in research management and innovation to fuel future growth.

Key outcomes already underway

Since joining the initiative, the university has implemented several key interventions. Most notably, the development and execution of standardised operating procedures have been introduced. These procedures ensure alignment with global standards, creating consistency across various functions within DRD. Such efforts not only improve operational efficiency, but also boost the university’s competitiveness in attracting international research collaborations and securing funding opportunities. Other platforms to promote visibility that the DRD has adopted this year include its newsletter, Research Nexus, webinars, and a presence on social media.

The SARIMA Visibility Project at the UFS is spearheaded by the DRD under the leadership of Dr Glen Taylor. As pioneers of the initiative, the DRD team is working closely with SARIMA to ensure the successful implementation of key strategies aimed at improving the research infrastructure and elevating the university’s global standing. Their leadership has been instrumental in driving efforts to meet the project's ambitious objectives. These objectives include promoting best practices in research and innovation management across the region. They aim to support the research and innovation ecosystem to drive regional social and economic development. Additionally, the project seeks to engage key stakeholders to strengthen collaboration. Another objective is to building capacity among research and innovation management practitioners through training and development initiatives.

The SARIMA project is closely aligned with the UFS’s Vision 130, a strategic roadmap designed to propel the institution into its 130th anniversary in 2034. Vision 130 seeks to elevate the university’s academic and research standing on the global stage. By enhancing international partnerships and refining research management practices, SARIMA is playing an important role in supporting the university in its goal of becoming a globally recognised research institution, in line with Vision 130.

Value added to the research environment

In the few months since its launch, the SARIMA initiative has already added significant value to the UFS Research Office. The introduction of standardised procedures has not only improved consistency across departments, but has also made the office more agile and responsive to the demands of international collaborations. Benchmarking exercises conducted as part of the project have allowed the university to identify key areas for improvement, adopting innovative solutions that further enhance the institution’s research capacity and global visibility.

The SARIMA Visibility Project marks a significant step forward for the university. It is not only a means of raising the institution’s profile, but also a platform for long-term sustainable research excellence. As the UFS continues to benefit from this initiative, it is setting the stage for a future of global recognition and academic achievement that will benefit both the institution and the broader academic community for years to come.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept